MAMA vs UDMY

The deterministic health and value scores indicate a severe valuation disconnect; the Piotroski F-Score is 4/9 (Stable), but the Graham Number ($1.81) and Intrinsic Value ($0.84) are drastically lower than the current price of $15.87. While the company exhibits impressive 50% YoY revenue growth and a healthy balance sheet (Debt/Equity 0.32), it is trading at an unsustainable P/E ratio of 132.25. With razor-thin profit margins of 3.08% and a bearish technical trend (10/100), the stock appears to be in a speculative bubble driven by growth expectations rather than fundamental value.

UDMY exhibits a strong deterministic health profile with a Piotroski F-Score of 7/9 and very low leverage (Debt/Equity 0.05), indicating a stable balance sheet. However, there is a severe valuation disconnect, as the current price of $5.06 trades at a massive premium to the Graham Number ($0.98) and Intrinsic Value ($0.21). While the Forward P/E of 8.13 suggests significant earnings recovery potential and analysts remain bullish, the company is struggling with negative revenue growth (-3.00% YoY) and razor-thin profit margins (0.48%). The outlook is a tug-of-war between fundamental financial stability and a lack of top-line growth momentum.